Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemangiosarcoma × Urination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Neoplasms 1 Liver Cirrhosis 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Hemangiosarcoma 1 Disease 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Hepatocellular 1

Interventions

Doxorubicin 15 Ifosfamide 9 pazopanib 6 Paclitaxel 6 pembrolizumab 4 Radiotherapy 4 Gemcitabine 4 Filgrastim 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Docetaxel 3 trebananib 2 cixutumumab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Trabectedin 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Conformal 2 Magnetic Resonance Spectroscopy 2 Imatinib Mesylate 2 Epirubicin 2 Carboplatin 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡